We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

RTW Biotech Opportunities Ltd (RTW) ORD NPV

Sell:$1.39 Buy:$1.44 0 Change: No change
Market closed Prices as at close on 24 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$1.39
Buy:$1.44
Change: No change
Market closed Prices as at close on 24 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$1.39
Buy:$1.44
Change: No change
Market closed Prices as at close on 24 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

RTW Biotech Opportunities Ltd is a Guernsey-based focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. The Company invests in companies developing therapies and technologies that can significantly improve patients' lives. The Company seeks to achieve its investment objective by leveraging the Investment Manager's data driven pipeline of assets to invest in life sciences companies across various therapeutic categories and product types (including genetic medicines, biologics, traditional modalities, such as small molecule pharmaceuticals and antibodies, and medical devices). It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. The Company's portfolio is managed by RTW Investments, LP.

Important dates

Future events
There are no future events available.
Past events
Interim results 13 September 2024 13/09/24
AGM 16 May 2024 16/05/24
Annual report 25 April 2024 25/04/24
Final results 28 March 2024 28/03/24
Annual report 28 March 2024 28/03/24

General stock information

EPIC:
RTW
ISIN:
GG00BKTRRM22
Market cap:
$475.03 million
Shares in issue:
335.71 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
US dollar
Indices:
n/a

Contact details

Address:
1st Floor
, Royal Chambers,, St Julian's Avenue,
PO Box 650
SAINT PETER PORT
GY1 3JX
Guernsey
Telephone:
+44 (01481) 742642
Website:
https://www.rtwfunds.com/rtw-biotech-opportunities-ltd/

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.